| Literature DB >> 27326910 |
Raffaele Nardone1, Slaven Pikija2, J Sebastian Mutzenbach2, Martin Seidl2, Stefan Leis2, Eugen Trinka3, Johann Sellner4.
Abstract
Spinal cord infarction (SCI) is a rare but disabling disorder caused by a wide spectrum of conditions. Given the lack of randomized-controlled trials, contemporary treatment concepts are adapted from guidelines for cerebral ischemia, atherosclerotic vascular disease, and acute traumatic spinal cord injury. In addition, patients with SCI are at risk for several potentially life-threatening but preventable systemic and neurologic complications. Notably, there is emerging evidence from preclinical studies for the use of neuroprotection in acute ischemic injury of the spinal cord. In this review, we discuss the current state of the art for the therapy and prevention of SCI and highlight potential emerging treatment concepts awaiting translational adoption.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27326910 DOI: 10.1016/j.drudis.2016.06.015
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851